Actualités RCTS

RWD92 Persistence and Patterns of Exposure to Omalizumab in Patients With Asthma in France Between 2009 and 2019 (SOLAIR Study)

RWD92 Persistence and Patterns of Exposure to Omalizumab in Patients With Asthma in France Between 2009 and 2019 (SOLAIR Study)

INTRODUCTION

While many studies have investigated compliance with omalizumab (OMA) in asthma patients, questions remain about exposure patterns.

We aimed to identify clusters of OMA exposure patterns in asthma patients, identifying OMA long-term discontinuation (≥ 1 year), separately for adults and children.

find the whole article here ==>https://www.valueinhealthjournal.com/article/S1098-3015(22)04522-3/fulltext

Authors
Deschildre A, Taillé C, Humbert M, Niarra R, Thonnelier C, Lajoinie A, et al.

Vous souhaitez échanger
avec nos équipes

Contactez-nous

D’autres articles qui pourraient
vous intéresser

Actualités RCTS

Webinaires évaluation clinique des dispositifs médicaux
Actualités RCTS

Webinaires évaluation clinique des dispositifs médicaux

La transmission chez RCTs, une valeur forte
Actualités RCTS

La transmission chez RCTs, une valeur forte